1-1 of 1
Konstantinos L. Bourantas, MD, PhD
Close
Sort by
Journal Articles

Epigenetic Profiling Identifies EGLN3 as a Frequent Target for Transcriptional Silencing in Plasma Cell Neoplasias.

Reshma Shah, Eleftheria Hatzimichael, MD, Nelofer Syed, PhD, Konstantinos L. Bourantas, MD, PhD, Tim Crook, MRCP, PhD
Journal: Blood
Blood (2007) 110 (11): 2132.
https://doi.org/10.1182/blood.V110.11.2132.2132
Published: 2007